Business Segments · Depreciation
Established Pharmaceuticals — Depreciation
Abbott Established Pharmaceuticals — Depreciation increased by 20.0% to $30.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 30.4%, from $23.00M to $30.00M. Over 4 years (FY 2021 to FY 2025), Established Pharmaceuticals — Depreciation shows relatively stable performance with a 1.8% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026
How to read this metric
High depreciation relative to assets may indicate a capital-intensive business or aging infrastructure requiring replacement.
Detailed definition
This metric represents the systematic allocation of the cost of tangible assets, such as manufacturing equipment and fac...
Peer comparison
Standard depreciation expense reported in segment notes for manufacturing-heavy businesses.
Metric ID:
abt_segment_established_pharmaceuticals_depreciationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 23.5M | 23.5M | 23.5M | 24.3M | 24.3M | 24.3M | 24.3M | 26M | 26M | 26M | 26M | 24M | 24M | 23M | 25M | 23M | 25M | 28M | 25M | 30M |
| QoQ Change | — | +0.0% | +0.0% | +3.2% | +0.0% | +0.0% | +0.0% | +7.2% | +0.0% | +0.0% | +0.0% | -7.7% | +0.0% | -4.2% | +8.7% | -8.0% | +8.7% | +12.0% | -10.7% | +20.0% |
| YoY Change | — | — | — | — | +3.2% | +3.2% | +3.2% | +7.2% | +7.2% | +7.2% | +7.2% | -7.7% | -7.7% | -11.5% | -3.8% | -4.2% | +4.2% | +21.7% | +0.0% | +30.4% |
Range23M – 30M
CAGR+5.3%
Avg YoY Growth+3.7%
Median YoY Growth+3.2%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Abbott's established pharmaceuticals — depreciation?
- Abbott (ABT) reported established pharmaceuticals — depreciation of $30.00M in Q1 2026.
- How has Abbott's established pharmaceuticals — depreciation changed year-over-year?
- Abbott's established pharmaceuticals — depreciation increased by 30.4% year-over-year, from $23.00M to $30.00M.
- What is the long-term trend for Abbott's established pharmaceuticals — depreciation?
- Over 4 years (2021 to 2025), Abbott's established pharmaceuticals — depreciation has grown at a 1.8% compound annual growth rate (CAGR), from $94.00M to $101.00M.
- What does established pharmaceuticals — depreciation mean?
- The non-cash expense representing the wear and tear of physical assets used by the segment.